Thrive With Type 1 Diabetes 2026
Purpose
This study aims to learn whether a cognitive behavioral intervention can improve lifestyle and glucose targets for adults with type 1 diabetes.
Condition
- Type1diabetes
Eligibility
- Eligible Ages
- Between 31 Years and 75 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Aged 31 to 75 years - Type 1 Diabetes for at least 1 year - One or more sleep health dimensions are out of range
Exclusion Criteria
- Non-English speaking - Recent night shift work or transmeridian travel - Life-limiting illness
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Other
- Masking
- None (Open Label)
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Experimental Transdiagnostic Intervention for Sleep and Circadian (TranS-C) Dysfunction Intervention Arm |
Participants will work with a health coach to aim for 7-9 hours of sleep per night, at least 85% sleep efficiency, and less than 60 minutes' variation in bed and wake times. |
|
|
Active Comparator Enhanced Usual Care (EUC) Arm |
Participants will work with a health coach focused on enhanced usual care. |
|
Recruiting Locations
Emory University, Nell Hodgson Woodruff School of Nursing
Atlanta, Georgia 30322
Atlanta, Georgia 30322
Emory University
Atlanta, Georgia 30329
Atlanta, Georgia 30329
More Details
- Status
- Recruiting
- Sponsor
- Emory University
Detailed Description
Type 1 diabetes (T1D), a common yet understudied chronic condition in young adulthood, is a life-shortening disorder leading to beta-cell destruction and absolute insulin deficiency. Suboptimal glucose diabetes self-management is associated with a higher risk for premature vascular complications, both macrovascular (e.g., coronary artery disease, peripheral arterial disease, and stroke) and microvascular (retinopathy, nephropathy, neuropathy) through accelerated vascular aging. Yet a majority of adults with T1D do not achieve recommended glycemic targets (A1C <7%) or blood pressure targets.